Phase IIIMitochondrial Peptide
Compound 61634
Formula Pending
Molecular Mass
N/A
CAS Registry
AUTO-061634
Risk Class
MODERATE
Last Audit
May 17, 2108
Research Abstract
Mitochondrial Peptide candidate engineered for cellular repair initiatives with automated dossier coverage.
Compound 61634 is a mitochondrial peptide asset inside mitochondrial peptide innovation track initiatives, optimized for cellular repair and tissue regeneration.
The dossier currently sits in phase iii with a moderate risk rating, meaning it is requires layered oversight with metabolic labs.
Supply records cite CAS AUTO-061634 with updates logged 2108-05-17.
Acquisition Protocol
Authorized research personnel may request deployment of this compound for laboratory analysis.
Primary Vectors
Cellular repairTissue regeneration
Nomenclature
CX-61634Mitochondrial Peptide Program 61634
Reference Material
- [1] Anubis Compound Registry • CAS AUTO-061634
- [2] Operations Pulse • Mitochondrial Peptide innovation track
- [3] Risk Governance Ledger • MODERATE clearance for COMPOUND-61634